Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Mol Psychiatry. 2009 Oct 20;15(1):29–37. doi: 10.1038/mp.2009.109

Table 1. Results of single marker analyses for SNPs in ZNF804A, NOS1 and RGRIP1L.

2-tailed p-values are shown for all tests and 1-tailed p-values are shown for the three previously reported SNPs

Locus Mbp SNP Allele fCases fControls Allelic OR (95% CI) CA (Z) 1t p 2t p HWE p
Chr 2 ZNF804A 185.19 rs13393273 G 0.44 0.4 1.17 (1.01–1.36) 2.107 0.0351 0.2684
185.19 rs17508595 G 0.31 0.27 1.21 (1.021.43) 2.285 0.0230 0.0809
185.20 rs12613195 C 0.7 0.67 1.15 (0.98 − 1.35) −1.687 0.0917 0.7266
185.22 rs12693385 T 0.57 0.54 1.11 (0.96 − 1.29) −1.421 0.1553 0.5129
185.24 rs7597593 T 0.44 0.38 1.28 (1.101.49) 3.212 0.0013 0.8647
185.26 rs1480481 C 0.41 0.35 1.13E-10
185.41 rs7605689 T 0.81 0.79 1.12 (0.93 − 1.35) −1.222 0.2216 0.4775
185.47 rs3931790 T 0.83 0.81 1.10 (0.91 − 1.34) −0.998 0.3181 0.8894
185.48 rs7603001 A 0.51 0.47 1.16 (1.00 − 1.34) −1.929 0.0537 0.7286
185.49 rs1344706 A (+) 0.65 0.61 1.20 (1.031.40) 2.279 0.0113 0.0227 0.0153
185.51 rs4667001 G 0.44 0.41 1.14 (0.98 − 1.32) −1.661 0.0966 0.6028
185.51 rs12477430 A 0.33 0.29 1.17 (1.00 − 1.38) −1.909 0.0563 0.7632

Mbp SNP Allele fCases fControls Allelic OR (95% CI) CA (Z) 1t p 2t p HWE p

Chr 12 NOS1 116.19 rs6490121 A 0.66 0.65 1.07 (0.91 − 1.25) −0.806 0.210 0.420 0.7591

Mbp SNP Allele fCases fControls Allelic OR (95% CI) CA (Z) 1t p 2t p HWE p

Chr 16 RGRIP1L 52.21 rs9922369 A (+) 0.03 0.02 1.57 (0.91 − 2.71) −1.631 0.0515 0.1029 1

Note that rs1344706 is here reported on the genomic (+) strand, where its alleles are A or C. Associated SNPs are shown in bold, (+) indicates the same allele as observed in the original study. Mbp: physical position in megabasepairs; fCases/Controls: Frequency of indicated allele in cases and controls respectively; CA (Z): Cochran-Armitage test statistic; 1t p, 2t p: one- and two-tailed p-values respectively; HWE p: Hardy-Weinberg equilibrium p-value.

HHS Vulnerability Disclosure